Concepedia

Alison Betts

AB

Statistics

Publications

22

Citations

1.9K

H-Index

18

Active since

2000

Affiliations

Pfizer (United States)(Current)

University at Buffalo, State University of New York

Renewable Energy Systems (United States)

Applied BioMath (United States)

Centre for Human Drug Research

Alison Betts is an author at Pfizer (United States) specializing in pharmacy, pharmacology, and pharmacokinetics.

ORCID

Publications per year

2000–2023

22

Publications

22

Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human

Dhaval K. Shah, Alison Betts · Journal of Pharmacokinetics and Pharmacodynamics · 2011 · 417 citations

, , +10

Antibody biodistribution coefficients

Dhaval K. Shah, Alison Betts · mAbs · 2013 · 252 citations · Full text

, , +17

A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions

Marc Damelin, Alexander J. Bankovich, Jeffrey Bernstein et al. · Science Translational Medicine · 2017 · 157 citations

, , +16

Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin

Dhaval K. Shah, Nahor Haddish‐Berhane, Alison Betts · Journal of Pharmacokinetics and Pharmacodynamics · 2012 · 156 citations

, , +15

Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach

Alison Betts, Anne Keunecke, Tamara J. van Steeg et al. · mAbs · 2018 · 108 citations · Full text

, , +17

1–5 of 22